Capitolis Liquid Global Markets’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARQT
Capitolis Liquid Global Markets's ARQT Position: Q3 2026 in Review
Capitolis Liquid Global Markets reduced its Arcutis Biotherapeutics (ARQT) stake by 8.2% in Q3 2026, selling an estimated $1.07M and leaving 459,100 shares worth $12.1M. The position accounts for 0.05% of the portfolio, ranked #176.
Capitolis Liquid Global Markets first reported a position in ARQT in Q4 2025 and has held it in 4 quarters since. The position peaked at $14.5M in Q4 2025. 293 funds tracked by Wall St. Rank hold ARQT as of Q3 2026.
- Capitolis Liquid Global Markets held 459,100 shares of Arcutis Biotherapeutics worth $12.1M as of Q3 2026.
- Capitolis Liquid Global Markets sold 40,900 Arcutis Biotherapeutics shares in Q3 2026, an estimated $1.07M.
- Arcutis Biotherapeutics made up 0.05% of Capitolis Liquid Global Markets's portfolio in Q3 2026, its #176 holding.
- Capitolis Liquid Global Markets first reported a position in Arcutis Biotherapeutics in Q4 2025 and has held it in 4 quarters since.
- Capitolis Liquid Global Markets's Arcutis Biotherapeutics position peaked at $14.5M in Q4 2025.
- 293 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2026.
Based on Capitolis Liquid Global Markets's 13F filing for Q3 2026, filed 12 Nov 2026.